CME GROUP INC.
Loading stock data...
Key Financial Metrics (TTM | FY 2025)
$6.52B
Revenue
$4.11B
Net Income
11.16
EPS (Diluted)
$7.57B
Free Cash Flow
Profitability
Gross Margin
-
Operating Margin
-
Net Profit Margin
63.01%
EBITDA
-
Returns & Efficiency
Return on Assets (ROA)
2.07%
Return on Equity (ROE)
14.30%
Gross Profit
-
Operating Income
-
Financial Health
Total Assets
$198.42B
Total Debt
-
Debt to Equity
5.91x
Current Ratio
-
Debt Analysis
Debt to EBITDA
-
Debt to Free Cash Flow
-
Cash & Equivalents
-
Net Debt
-
Capital Returns
Return on Invested Capital (ROIC)
-
Invested Capital
-
Stockholders Equity
-
Revenue Growth
-
Market Valuation
Market Cap
-
P/E Ratio
-
Price to Book
-
EPS (Diluted)
$11.16
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Insider Transactions
Neutral
Open Market Buys: -
Open Market Sales: -
Option Exercise & Sale: -
Net: -
Loading...
Loading insider transactions...
My Notes & Files
Personal Notes
Attached Files
Loading...
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address |
20 S. WACKER DR.
CHICAGO, IL 60606 |
| Phone | 3129301000 |
| Incorporated | DE, US |
| EIN | 364459170 |
| Fiscal Year End | 1231 |
| Stockholders' Equity | $28.73B |
Recent Filings
View All
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-09
Local
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-03-05
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2026-02-26
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-02-23
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-23
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-20
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-02-18
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-09
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-02-06
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-10-24
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-07-25
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-04-30
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2025-03-20
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2025-02-27
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-11-08
Local
Financial Statistics
Valuation
Market Cap
-
P/E Ratio (TTM)
-
Price to Book
-
EV/Revenue
-
EV/EBITDA
-
Profitability
Gross Margin
-
Operating Margin
-
Net Margin
63.0%
ROE
14.3%
ROA
2.1%
Leverage & Liquidity
Debt to Equity
5.91
Current Ratio
-
Total Debt
-
Total Assets
$198.42B
Stockholders' Equity
$28.73B
Income Statement (FY 2025)
Revenue
$6.52B
Gross Profit
-
Operating Income
-
Net Income
$4.11B
EPS (Diluted)
$11.16
Cash Flow (FY 2025)
Free Cash Flow
$7.57B
Cash & Equivalents
-
Revenue Growth
6.4%
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...